VNDA has been in the news 450% more than usual
Jan 02, 2026, 5:32 PM
3.19%
What does VNDA do
Vanda Pharmaceuticals, headquartered in Washington, D.C., develops therapies for unmet medical needs and has three commercial products, including HETLIOZ and Fanapt. The company also has multiple drugs in development.
VNDA has been in the news recently: Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) experienced an increase in its share price following FDA approval for its product NEREUS, which is designed to prevent motion-induced vomiting. In contrast, FuelCell Energy, Inc. (NASDAQ: FCEL) saw a significant drop in its shares due to the announcement of an amended common stock offering.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.